Skip to content
MarketScale
‹ Back to IndustriesHealthcare

The U.K. Bans Microbeads

If you’ve ever exfoliated your skin or brushed your teeth with toothpaste, you’ve probably used a microbead. Microbeads are the tiny plastic spheres found in many exfoliating facial scrubs, shower gels, toothpastes and other rinse-off skincare products on the market. They are in the class of microplastics, pieces of plastic less than five millimeters, or…

This story was produced through MarketScale. See how Healthcare teams put it to work with Executive Thought Leadership.

Share

If you’ve ever exfoliated your skin or brushed your teeth with toothpaste, you’ve probably used a microbead. Microbeads are the tiny plastic spheres found in many exfoliating facial scrubs, shower gels, toothpastes and other rinse-off skincare products on the market. They are in the class of microplastics, pieces of plastic less than five millimeters, or 0.2-inches, long. Found in chewing gum, glitter, industrial cleaning products, synthetic clothing fibers and even tires, microplastics are everywhere, and that’s a big problem for the world’s oceans.

Because they’re so small, microbeads cannot be filtered out by wastewater treatment plants and end up in the watershed. From there, they are inadvertently eaten by fish and other marine animals—the very fish and marine animals that are an important part of the food chain. This means humans ultimately end up eating the very plastic they were using to wash their faces. This can cause hormone disruptions and cancer. In response to health concerns, the U.K. government pledged to ban the manufacturing of cosmetic products containing microbeads in 2016. The ban just took effect on January 8, 2018 and joins similar bans enacted by the U.S., Canada, and New Zealand.

While this move is certainly a positive for the world’s ocean ecosystems and our own food chain, plastic in its many forms remains a problem for the environment, for ocean animals, and for our own health. Some municipalities are looking to tax or ban plastic grocery bags or plastic-coated cups, and leaders are calling for a reduction in the use of bottled water packaged in plastic.

Healthcare: are you visible to AI?

Before they reach out, Healthcare buyers ask AI engines which vendors to trust. See how AI describes your company today, and where competitors show up instead.

Free workspace

You just read one expert. Imagine publishing your whole team.

This article was produced through MarketScale. Create a free workspace and turn your own team's expertise into articles, video, and social posts. No credit card, no demo required.

NPS +73 · 1,000+ creators · 38+ countries

What you get, free

Your own MarketScale Studio workspace
One video edit a month, on us
AI writing, editing, and publishing tools
In-platform coaching to learn the system

More Healthcare Insights

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

FDA clears UpDoc's LLM diabetes app, grants Aidoc breakthrough status as clinical AI crosses new regulatory thresholds

UpDoc has received FDA clearance for its LLM-driven diabetes management app, while Aidoc has been granted breakthrough device status for its AI-drafted radiology reports. This marks a significant milestone as clinical AI applications continue to gain regulatory approval and recognition. The advancements showcase the potential of AI in improving healthcare management and diagnostic processes.

  • 01UpDoc's diabetes management app receives FDA clearance.
  • 02Aidoc achieves breakthrough device status for AI radiology reports.
  • 03Regulatory milestones highlight AI's growing role in healthcare.

Jul 13, 2026

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

Cedars-Sinai's CDAIO on healthcare AI's second wave: workforce transformation, not just productivity

The chief data and AI officer at Cedars-Sinai discusses the evolving role of AI in healthcare. While the first wave of AI focused on enhancing productivity, the second wave is expected to transform job roles and the workforce structure. This shift indicates a deeper integration of AI technology in healthcare operations.

  • 01First wave of AI increased productivity in healthcare.
  • 02Second wave aims to restructure job roles.
  • 03AI will deeply integrate into healthcare operations.

Jul 13, 2026

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation adoption gap widens in US manufacturing as medtech presses ahead

Automation in US manufacturing lags, with 80% of factories lacking automation tools. In contrast, medtech manufacturers are advancing with technologies like micro-molding and ultrasonic welding. This disparity highlights a growing gap in technology adoption across different sectors.

  • 0180% of US factories have no automation.
  • 02Medtech manufacturers are investing in automation technologies.
  • 03There's an increasing divide in technology adoption across industries.

Jul 12, 2026

Explore More Healthcare Insights

Read more expert perspectives from across Healthcare.

Browse Healthcare Hub